With mixed quarter results for the June quarter, Holista Colltech (ASX: HCT) – a research-driven biotech company, is trying to stay afloat amidst challenges. Dedicated to developing and commercialising innovative food products, the Perth based company has seen a decline of 3.7% in overall sales receipts. With a focus on natural ingredients the company has
Read More
Medical diagnostics company Rhythm Biosciences (ASX: RHY) has undertaken a comprehensive strategic review following major shareholder discontent and a subsequent S249D notice requesting a vote to remove the Chairman. In October, the Company faced regulatory scrutiny as its stock value plunged from 32¢ to 20¢, triggering an ASX “speeding ticket”. Later, the stock was trading
Read More
As the world emerges from the pandemic which has emphasised the critical importance of vaccination, Apiam Animal Health (ASX: AHX) has identified an opportunity to position Australia as leaders in autogenous vaccine manufacturing through the development of a state-of-the-art viral vaccine laboratory in Bendigo, Victoria. Plans to develop the vaccine lab have been announced, supported
Read More